Hepatopulmonary syndrome screening: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
OR | OR | ||
According to the [guideline name], screening for | According to the [guideline name], screening for hepatopulmonary syndrome is not recommended. | ||
OR | OR | ||
According to the [guideline name], screening for | According to the [guideline name], screening for hepatopulmonary syndrome by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | There is insufficient evidence to recommend routine screening for [disease/malignancy]. | ||
| Line 18: | Line 18: | ||
OR | OR | ||
According to the [guideline name], screening for | According to the [guideline name], screening for hepatopulmonary syndrome is not recommended. | ||
OR | OR | ||
According to the [guideline name], screening for | According to the [guideline name], screening for hepatopulmonary syndrome by [test 1] is recommended every [duration] among patients with: | ||
*[Condition 1] | *[Condition 1] | ||
*[Condition 2] | *[Condition 2] | ||
Revision as of 16:09, 19 July 2019
|
Hepatopulmonary syndrome Microchapters |
|
Differentiating Hepatopulmonary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatopulmonary syndrome screening On the Web |
|
American Roentgen Ray Society Images of Hepatopulmonary syndrome screening |
|
Risk calculators and risk factors for Hepatopulmonary syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for hepatopulmonary syndrome is not recommended.
OR
According to the [guideline name], screening for hepatopulmonary syndrome by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for hepatopulmonary syndrome is not recommended.
OR
According to the [guideline name], screening for hepatopulmonary syndrome by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]